Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Unpurified Cremophor EL on the Solution Stability of Paclitaxel

By Gogate Uday   Schwartz Philip   Agharkar Shreeram  

Pharmaceutical Development and Technology, Vol. 14, Iss. 1, 2009-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Localized delivery of paclitaxel using elastic liposomes: Formulation development and evaluation

By Utreja Puneet   Jain Subheet   Tiwary A. K.  

Drug Delivery, Vol. 18, Iss. 5, 2011-07 ,pp. : 367-376

Informa Healthcare

Access to resources Recommend Favorite

Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation

By Kang Myung J.   Kim Bo G.   Eum Jae Y.   Park Sang H.   Choi Sun E.   An Jae J.   Jang Sang H.   Eum Won S.   Lee Jaehwi   Lee Min W.   Kang Kyungho   Oh Chil H.   Choi Soo Y.   Choi Young W.  

Journal of Drug Targeting, Vol. 19, Iss. 7, 2011-08 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Elastic Liposomal Formulation for Sustained Delivery of Antimigraine Drug: In Vitro Characterization and Biological Evaluation

By Garg Twinkal   Jain Subheet   Singh Hardevinder Pal   Sharma Arvind   Tiwary A. K.  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 10, 2008-10 ,pp. : 1100-1110

Informa Healthcare

Access to resources Recommend Favorite